BlackRock’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.8M | Sell |
4,217,933
-2,929
| -0.1% | -$22.1K | ﹤0.01% | 2719 |
|
|
2025
Q1 | $32M | Sell |
4,220,862
-150,163
| -3% | -$1.14M | ﹤0.01% | 2614 |
|
|
2024
Q4 | $53.2M | Buy |
4,371,025
+32,300
| +0.7% | +$393K | ﹤0.01% | 2383 |
|
|
2024
Q3 | $72.6M | Buy |
4,338,725
+788,518
| +22% | +$13.2M | ﹤0.01% | 2232 |
|
|
2024
Q2 | $61.9M | Buy |
3,550,207
+1,121,214
| +46% | +$19.6M | ﹤0.01% | 2265 |
|
|
2024
Q1 | $41.4M | Sell |
2,428,993
-33,281
| -1% | -$567K | ﹤0.01% | 2502 |
|
|
2023
Q4 | $25.1M | Buy |
2,462,274
+225,989
| +10% | +$2.3M | ﹤0.01% | 2827 |
|
|
2023
Q3 | $20.2M | Buy |
2,236,285
+132,216
| +6% | +$1.2M | ﹤0.01% | 2886 |
|
|
2023
Q2 | $22.6M | Sell |
2,104,069
-151,528
| -7% | -$1.63M | ﹤0.01% | 2895 |
|
|
2023
Q1 | $23.1M | Sell |
2,255,597
-250,618
| -10% | -$2.56M | ﹤0.01% | 2850 |
|
|
2022
Q4 | $26.4M | Buy |
2,506,215
+131,390
| +6% | +$1.39M | ﹤0.01% | 2832 |
|
|
2022
Q3 | $30.4M | Buy |
2,374,825
+143,098
| +6% | +$1.83M | ﹤0.01% | 2757 |
|
|
2022
Q2 | $28.6M | Buy |
2,231,727
+405,558
| +22% | +$5.2M | ﹤0.01% | 2832 |
|
|
2022
Q1 | $19.1M | Sell |
1,826,169
-12,943
| -0.7% | -$136K | ﹤0.01% | 3127 |
|
|
2021
Q4 | $28.4M | Buy |
1,839,112
+209,518
| +13% | +$3.23M | ﹤0.01% | 2992 |
|
|
2021
Q3 | $36.8M | Buy |
1,629,594
+687,316
| +73% | +$15.5M | ﹤0.01% | 2832 |
|
|
2021
Q2 | $24.3M | Buy |
942,278
+54,470
| +6% | +$1.4M | ﹤0.01% | 3133 |
|
|
2021
Q1 | $37M | Buy |
+887,808
| New | +$37M | ﹤0.01% | 2779 |
|